isatin has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Casella, L; Costa, LAS; da Costa Ferreira, AM; Machini, MT; Monzani, E; Novato, WTG; Pirota, V; Wegermann, CA | 1 |
| Boukos, N; Kaminari, A; Mavroidi, B; Pelecanou, M; Sagnou, M | 1 |
| Altomare, CD; Catto, M; Cellamare, S; de Candia, M; Espargaró, A; Gambacorta, N; Nicolotti, O; Pisani, L; Purgatorio, R; Sabaté, R | 1 |
| Akkinepally, R; Garige, AK; Garlapati, A; Kulkarni, R; Macha, B; Palabindala, R | 1 |
| Buneeva, OA; Gnedenko, OV; Ivanov, AS; Medvedev, AE; Medvedeva, MV | 1 |
| Edraki, N; Miri, R; Nadri, H; Riazimontazer, E; Sadeghpour, H; Sakhteman, A; Tüylü Küçükkılınç, T | 1 |
| Buneeva, OA; Gnedenko, OV; Ivanov, AS; Kopylov, AT; Kozin, SA; Makarov, AA; Medvedev, AE; Medvedeva, MV; Zgoda, VG | 1 |
7 other study(ies) available for isatin and Alzheimer Disease
| Article | Year |
|---|---|
Interaction studies of oxindole-derivatives with β-amyloid peptides inhibiting its aggregation induced by metal ions.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Humans; Ions; Isatin; Ligands; Metals; Oxindoles; Peptide Fragments; Zinc | 2023 |
Novel Isatin Thiosemicarbazone Derivatives as Potent Inhibitors of β-Amyloid Peptide Aggregation and Toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Isatin; Peptide Fragments; Thiosemicarbazones | 2020 |
Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chemistry Techniques, Synthetic; Cytoprotection; Drug Design; Humans; Indoles; Isatin; Ligands; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Peptide Fragments; Protein Aggregates; Quantitative Structure-Activity Relationship | 2020 |
Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isatin; Molecular Docking Simulation; Neurodegenerative Diseases; Quinolines; Schiff Bases; Structure-Activity Relationship | 2022 |
[The effect of the neuroprotector isatin on complex formation of beta-amyloid peptide fragments with some intracellular proteins].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Isatin; Peptide Fragments | 2018 |
Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Horses; Humans; Isatin; Molecular Docking Simulation; Molecular Structure; Peptide Fragments; Protein Aggregates; Schiff Bases; Structure-Activity Relationship; Tacrine | 2019 |
The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease?
Topics: Actins; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Glyceraldehyde-3-Phosphate Dehydrogenases; Hydrogen Peroxide; Isatin; Male; Protein Binding; Protein Interaction Maps; Proteomics; Rats | 2014 |